CClinicalTrials.gg
Active, not recruitingNCT06744699MESK-1Updated Dec 20, 2024

Assessment of Gastrointestinal Discomfort and Infections in Healthy Term Infants

An observational study in Gastrointestinal Symptoms, Infection and Allergy Symptoms, sponsored by Ausnutria Hyproca B.V.. Active, not recruiting at 3 sites in Saudi Arabia. Open to participants aged Up to 24 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-20.

Sponsored by Ausnutria Hyproca B.V. · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
300
Ages
Up to 24 Months
Sex
All
01

Study summary

A retrospective observational medical dossier-based study to assess gastrointestinal discomfort and infections in healthy term infants

Read the detailed description

Gastrointestinal (GI) symptoms like regurgitation, unexplained crying and stool issues (diarrhoea or constipation) are common in young infants \<4 months of age due to an immature gut epithelial barrier, immune system and microbiota, with studies indicating prevalences ranging from 25.9%-78%. This retrospective observational medical dossier-based study is designed to determine the occurrence of GI symptoms in healthy term formula-fed infants to confirm reported prevalence of mild GI symptoms by HCPs in Middle East (74%). As a secondary objective, the improvement of confirmed GI symptoms when switched before 4 months of age from a CMF to GMF will be determined. Based on the results of a previous study in infants with confirmed GI symptoms, it is expected that fewer GI symptoms will be scored in medical dossiers of infants after switching from CMF to GMF, with HM as a reference group. Other secondary objectives of this study are to explore differences between healthy term infants that were fed GMF compared to infants fed CMF or HM on immune related outcomes such as infections and allergies, medication use related to infections and/or gastrointestinal discomfort and/or allergies, number of clinic visits, adequate growth and reason of changing infant formula.

02

Conditions studied

  • Gastrointestinal Symptoms
  • Infection
  • Allergy Symptoms
  • Growth

Keywords

  • infant
  • retrospective
  • medical dossier-based study
  • GI symptoms
  • infection symptoms
  • allergy symptoms
  • type of feeding
  • growth
03

In context

Infections

6,687 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's planned enrollment of 300 is above the median of 240 across 2,136 observational studies indexed under Infections.

Browse Infections studies →

Lead sponsor

Ausnutria Hyproca B.V. is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 24 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of 300 healthy term infants with medical dossiers covering the period of 0-12 months of age and at least 6 clinic visits.

Inclusion criteria

  • Either exclusively formula fed (GMF or CMF; consumption of HM ≤2 weeks is allowed for formula fed infants) OR exclusively breastfed before introduction of complementary feeding.
  • Age 12-24 months of age to ensure collection of recent data.
  • If required by local regulation or guidelines, written informed consent (ICF) from Investigator (or parent(s) and/or caregiver(s)* aged ≥18 years).
  • Singleton, term infants (gestational age ≥ 37 weeks and ≤ 42 weeks).
  • At least 6 reported visits to the doctor between 0-12 months of age.

Exclusion criteria

Exclusion Criteria:

  • Consumed hydrolysed infant formula or other specialty formulas.
  • Any current or previous illnesses/conditions and/or known congenital diseases or malformations which could interfere with the study outcomes, as per Investigator's clinical judgement.
  • Participation in any clinical trial during first year of life.
  • For formula-fed infant, no switch in feeding type after 4 months of age is allowed.
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Formula-fed infants

    Formula-fed infants either goat milk-based infant formula or cow's milk-based infant formula

    Other: Infants fed goat milk-based infant formula

Interventions

  • OtherInfants fed goat milk-based infant formula

    Type of infant feeding during the age of 0-12 months

    Also known as: Infants fed cow's milk based infant formula, Infants breastfed / human milk feeding

06

What researchers measure

Primary outcomes

  1. To investigate the occurrence of symptoms related to GI discomfort in formula-fed infants in the Gulf region

    To determine the number of symptoms related to GI discomfort in formula-fed infants between 0-12 months of age

    Time frame: retrospective infants from 0 - 12 months of age

07

Study locations

3 sites
  • Al Emies hospital
    Gizan, Saudi Arabia
  • Mana GH Jubail
    Jubail, Saudi Arabia
  • AlAhmady Hospital
    Medina, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06744699
Lead sponsor
Ausnutria Hyproca B.V.
Responsible party
Sponsor
First posted
Dec 20, 2024
Start date
Nov 18, 2024
Primary completion
Feb 2025 (estimated)
Completion
Feb 2025 (estimated)
Last update
Dec 20, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion